Suppr超能文献

大鼠肝脏中β-肾上腺素能受体拮抗剂3H-二氢阿普洛尔和125I-碘氰吲哚洛尔结合特性的比较。

A comparison of the binding characteristics of the beta-adrenoceptor antagonists 3H-dihydroalprenolol and 125I-iodocyanopindolol in rat liver.

作者信息

Sandnes D, Westergren T, Sand T E, Sager G, Refsnes M, Christoffersen T, Jacobsen S

出版信息

Acta Pharmacol Toxicol (Copenh). 1984 Oct;55(4):287-96. doi: 10.1111/j.1600-0773.1984.tb01984.x.

Abstract

The binding characteristics of 3H-dihydroalprenolol and 125I-iodocyanopindolol have been compared in a particulate fraction from regenerating rat liver. When total 3H-dihydroalprenolol binding and inhibition of total 3H-dihydroalprenolol binding by (-)isoprenaline, (-)alprenolol and (+/-)cyanopindolol was investigated, it was found that all agents were bound to two classes of saturable binding sites. In the inhibition studies, the presence of two binding components was not obvious until the data were transformed into Hofstee plots and these were decomposed, except in the case of (+/-)cyanopindolol. Only (+/-)cyanopindolol was found to distinguish clearly between the two saturable binding sites identified by 3H-dihydroalprenolol, as indicated by a broad plateau in the inhibition curve. When 125I-iodocyanopindolol was used as radioligand, only one saturable binding site was identified, even in the presence of less selective inhibiting ligands. The lower affinity component of 3H-dihydroalprenolol binding could be inhibited by 10 microM phentolamine. However, binding experiments with 3H-prazosin indicated that the lower affinity component was not identical with the alpha-adrenoceptor. Phentolamine did not influence 125I-iodocyanopindolol binding. Thus, due to its higher specific activity and a high degree of selectivity, 125I-iodocyanopindolol appears to be the ligand of choice.

摘要

在再生大鼠肝脏的微粒体部分中,对3H-二氢阿普洛尔和125I-碘氰吲哚洛尔的结合特性进行了比较。当研究总的3H-二氢阿普洛尔结合以及(-)异丙肾上腺素、(-)阿普洛尔和(±)氰吲哚洛尔对总的3H-二氢阿普洛尔结合的抑制作用时,发现所有药物都与两类可饱和结合位点结合。在抑制研究中,直到将数据转换为霍夫斯泰因图并进行分解,才明显看出存在两种结合成分,但(±)氰吲哚洛尔的情况除外。只有(±)氰吲哚洛尔能够清楚地区分由3H-二氢阿普洛尔确定的两个可饱和结合位点,抑制曲线中有一个宽平台表明了这一点。当使用125I-碘氰吲哚洛尔作为放射性配体时,即使存在选择性较低的抑制性配体,也只鉴定出一个可饱和结合位点。3H-二氢阿普洛尔结合的低亲和力成分可被10微摩尔酚妥拉明抑制。然而,用3H-哌唑嗪进行的结合实验表明,低亲和力成分与α-肾上腺素受体并不相同。酚妥拉明不影响125I-碘氰吲哚洛尔的结合。因此,由于其较高的比活性和高度的选择性,125I-碘氰吲哚洛尔似乎是首选的配体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验